Cabozantinib for progressive metastatic medullary thyroid cancer: a review

Medullary thyroid cancer is uncommon and patients typically present with advanced disease. Treatment options for patients with progressive, metastatic medullary thyroid cancer had been limited until recently. Tyrosine kinase inhibitors have garnered increasing interest in this subset of patients. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Joshua R, Wein, Richard O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043815/
https://www.ncbi.nlm.nih.gov/pubmed/24920914
http://dx.doi.org/10.2147/TCRM.S46041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043815/
https://www.ncbi.nlm.nih.gov/pubmed/24920914
http://dx.doi.org/10.2147/TCRM.S46041

Ejemplares similares